Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.72x
INDRAMEDCO's operating cash flow covered 72% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹1.20B
INDRAMEDCO's free cash flow was ₹1.20B in FY 2025, down 7.9% from FY 2024.
Dividend Coverage
3.0x
INDRAMEDCO's free cash flow covered dividends 3.0x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
23.2%
Capital expenditure was 23.2% of operating cash flow in FY 2025 for INDRAMEDCO, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 1.66B | 2.16B | |
| Cash flow Operating Activities | 2.00B | 1.57B | |
| Investments in PPE | -693.90M | -363.30M | |
| Cash flow Investing Activities | -1.58B | -1.11B | |
| Dividend Paid | -275.40M | -407.30M | |
| Cash flow Financing Activities | -323.80M | -458.80M | |
| Cash at beginning of period | 522.60M | 616.00M | |
| Cash at end of period | 616.00M | 614.80M | |
| Free Cash Flow | 1.31B | 1.20B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025